Oric Pharmaceuticals, Inc. SEC filings ORIC
Oric Pharmaceuticals, Inc. has 423 filings in SEC EDGAR's recent list, going back to Dec 13, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
May 28, 2025 | May 23, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2025 | Feb 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 22, 2024 | Jan 20, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Other events
|
Oct 23, 2023 | Oct 21, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jun 27, 2023 | Jun 24, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 24, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Other events
|
Dec 21, 2022 | Dec 21, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2022 | Jun 17, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 21, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2022 | Mar 21, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 10, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Other events
|
Oct 7, 2021 | Oct 7, 2021 |
| 8-K |
Current report
Other events
|
Aug 18, 2021 | Aug 17, 2021 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Aug 16, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Other events
|
Jul 12, 2021 | Jul 8, 2021 |
| 8-K |
Current report
Other events
|
Jul 8, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 21, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Material agreement
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Other events
|
Oct 19, 2020 | Oct 19, 2020 |
| 8-K |
Current report
Results of operations, Unregistered share sale, Regulation FD disclosure
|
Aug 5, 2020 | Aug 3, 2020 |
| 8-K |
Current report
Officer or director change
|
Jun 10, 2020 | Jun 9, 2020 |
| 8-K |
Current report
Results of operations
|
May 20, 2020 | May 20, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Apr 28, 2020 | Apr 28, 2020 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORIC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1796280
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.